Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
All News
Headline News
Benzinga
Chartmill
The Motley Fool
InvestorPlace
Investor's Business Daily
MarketBeat
Talk Markets
Press Releases
24-7 Press Release
AB Newswire
ACCESSWIRE
ACN Newswire
Authority Press Wire
Binary News Network
Brandpoint
Business Wire
CannabisNewsWire
CryptoCurrencyWire
eTrendy Stock
FinancialNewsMedia
Get News
getfeatured.news
GlobePRwire
Globe NewsWire
InvestorBrandNetwork
JCN Newswire
Law Firm Newswire
MediaOutReach
MerxWire
News Direct
Newsfile
NewsUSA
Newswire.com
Newsworthy.ai
Press Advantage
Press Release Distribution Service
PressConnect.ai
PressReach
PRLeap
PRLog
Prodigy
ReleaseWire
Small Business Trendsetters
StatePoint
Syndication Cloud
TheNewswire
Zexprwire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
DOCS INVESTOR NEWS: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS
May 23, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Tickers
DOCS
HRBR Stockholders: Robbins LLP Reminds HRBR Stockholders of Securities Fraud Class Action Against Harbor Diversified, Inc.
May 23, 2024
From
Robbins LLP
Via
GlobeNewswire
Tickers
HRBR
INTC Stockholders: Robbins LLP Reminds INTC Stockholders of Securities Fraud Class Action Against Intel Corporation
May 23, 2024
From
Robbins LLP
Via
GlobeNewswire
Tickers
INTC
Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
May 23, 2024
From
Fresh2 Group Ltd
Via
GlobeNewswire
Tickers
FRES
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024
From
Kronos Bio, Inc.
Via
GlobeNewswire
Tickers
KRON
SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024
From
SpringWorks Therapeutics, Inc.
Via
GlobeNewswire
Tickers
SWTX
Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant improvement in overall survival of newly diagnosed glioblastoma patients
May 23, 2024
From
Ivy Brain Tumor Center
Via
GlobeNewswire
G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting
May 23, 2024
From
G1 Therapeutics
Via
GlobeNewswire
Tickers
GTHX
Elcora Announces Share Consolidation
May 23, 2024
From
Elcora Advanced Materials Corp.
Via
GlobeNewswire
Tickers
ECORF
TSX-V:ERA
Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study in EGFR Wild-Type Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology 2024
May 23, 2024
From
Affimed N.V.
Via
GlobeNewswire
Tickers
AFMD
Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combination with a Checkpoint Inhibitor and Updated Monotherapy Data at ASCO 2024
May 23, 2024
From
Cullinan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CGEM
Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Combination with Libtayo® (cemiplimab) to be Reported at ASCO
May 23, 2024
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
REGN
HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting
May 23, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
Tickers
HOOK
Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Congress
May 23, 2024
From
Arvinas Inc.
Via
GlobeNewswire
Tickers
ARVN
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
May 23, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Tickers
IOVA
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Tickers
BPTH
Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors
May 23, 2024
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Werewolf Therapeutics to Present Updated Data from Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors at 2024 ASCO Annual Meeting
May 23, 2024
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
Tickers
HOWL
Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting
May 23, 2024
From
Kymera Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KYMR
Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting
May 23, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
May 23, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
MAQUIA CAPITAL ACQUISITION CORPORATION AND IMMERSED INC. MUTUALLY AGREE TO TERMINATE BUSINESS COMBINATION AGREEMENT
May 23, 2024
From
Maquia Capital Acquisition Corporation
Via
GlobeNewswire
Tickers
MAQC
MAQCU
MAQCW
Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment at 2024 ASCO Annual Meeting
May 23, 2024
From
Candel Therapeutics
Via
GlobeNewswire
Tickers
CADL
Tizona Therapeutics Presents Phase 1b TTX-080 Clinical Data in Advanced Colorectal Cancer and Head and Neck Squamous Cell Carcinoma at ASCO 2024
May 23, 2024
From
Tizona Therapeutics Inc
Via
GlobeNewswire
Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m HNSCC at the 2024 ASCO® Annual Meeting
May 23, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
THOR Industries Announces Date For Its Fiscal 2024 Third Quarter Earnings Release
May 23, 2024
From
THOR Industries, Inc.
Via
GlobeNewswire
Tickers
THO
HUB Security Provides an Update on the 2023 Annual Report
May 23, 2024
From
HUB Cyber Security Ltd.
Via
GlobeNewswire
Tickers
HUBC
Philips successfully prices offering of Notes for EUR 700 million to be used for repayment of existing debt
May 23, 2024
From
Royal Philips
Via
GlobeNewswire
Tickers
PHG
Interpublic Declares Common Stock Dividend
May 23, 2024
From
Interpublic Group of Companies, Inc. (The)
Via
GlobeNewswire
Tickers
IPG
Lilium Announces Launch of Offering of Class A Shares and Warrants
May 23, 2024
From
Lilium GmbH
Via
GlobeNewswire
Tickers
LILM
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.